Abstract
Introduction/BackgroundPreviously, we identified lipolysis-stimulated lipoprotein receptor (LSR) as a new target of epithelial ovarian cancer (EOC), and we reported anti-tumor effect of our newly developed monoclonal antibody (mAb) against LSR-positive...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have